GT Biopharma Inc (GTBP)
3.75
-0.11
(-2.85%)
USD |
NASDAQ |
May 31, 16:00
3.72
-0.03
(-0.80%)
After-Hours: 20:00
GT Biopharma Cash from Financing (Quarterly): 0.00 for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 6.268M |
| December 31, 2022 | -0.001M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.223M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.137M |
| June 30, 2021 | 16.24M |
| March 31, 2021 | 25.94M |
| December 31, 2020 | 6.874M |
| September 30, 2020 | 1.20M |
| June 30, 2020 | 4.257M |
| March 31, 2020 | 0.20M |
| December 31, 2019 | 0.20M |
| September 30, 2019 | 0.975M |
| June 30, 2019 | 1.30M |
| March 31, 2019 | 0.952M |
| December 31, 2018 | 0.104M |
| September 30, 2018 | 3.571M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 6.522M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 4.93M |
| June 30, 2017 | 0.195M |
| March 31, 2017 | 0.866M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.362M |
| June 30, 2016 | 1.39M |
| March 31, 2016 | 0.15M |
| December 31, 2015 | 0.95M |
| September 30, 2015 | 0.55M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 2.35M |
| December 31, 2014 | 1.254M |
| September 30, 2014 | 1.24M |
| June 30, 2014 | 0.039M |
| March 31, 2014 | 0.05M |
| December 31, 2013 | 0.424M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.001M |
| December 31, 2012 | 0.315M |
| September 30, 2012 | 0.207M |
| June 30, 2012 | 0.188M |
| March 31, 2012 | 0.22M |
| December 31, 2011 | 0.416M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.223M
Minimum
Jun 2022
25.94M
Maximum
Mar 2021
3.168M
Average
0.1685M
Median
Cash from Financing (Quarterly) Benchmarks
| Cutera Inc | -0.26M |
| Oragenics Inc | 1.653M |
| Outlook Therapeutics Inc | 56.14M |
| 180 Life Sciences Corp | -0.2644M |
| Scorpius Holdings Inc | 3.275M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.163M |
| Cash from Investing (Quarterly) | 5.034M |
| Free Cash Flow | -10.11M |
| Free Cash Flow Per Share (Quarterly) | -3.015 |
| Free Cash Flow Yield | -195.2% |